BRIEF published on 07/11/2024 at 07:10, 2 years ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Financial Results Clinical Trial Heidelberg Pharma HDP-101 Multiple Myeloma
PRESS RELEASE published on 07/11/2024 at 07:05, 2 years ago Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business Heidelberg Pharma AG reports positive preliminary efficacy data for HDP-101 in multiple myeloma clinical trial. Key events include AACR Meeting presentation & FDA Orphan Drug Designation Clinical Trial HDP-101 Heidelberg Pharma AG AACR Meeting FDA Orphan Drug Designation
BRIEF published on 06/21/2024 at 11:21, 2 years 1 month ago Heidelberg Pharma Reports on the Results of the Annual General Meeting 2024 Shareholders Financial News Resolutions Heidelberg Pharma AGM 2024
PRESS RELEASE published on 06/21/2024 at 11:16, 2 years 1 month ago Heidelberg Pharma reports on the results of the Annual General Meeting 2024 Heidelberg Pharma AG reports on the results of the Annual General Meeting 2024, including approval of resolutions and shareholder attendance Shareholders Voting Results Annual General Meeting 2024 Cancer Therapy Heidelberg Pharma AG
BRIEF published on 06/18/2024 at 13:52, 2 years 1 month ago Heidelberg Pharma AG Announces Updated Guidance for 2024 Revenue Forecast Financial Guidance Biotech Heidelberg Pharma AG Operating Expenses
PRESS RELEASE published on 06/18/2024 at 13:47, 2 years 1 month ago EQS-Adhoc: Heidelberg Pharma AG announces updated guidance Heidelberg Pharma AG updates guidance for fiscal year 2024, lowering sales expectations due to delays and adjusting operating expenses. Financing secured until mid-2025 with potential expansion until end of 2026 Financial Year 2024 Heidelberg Pharma AG Operating Expenses Sales Expectations Updated Guidance
BRIEF published on 05/23/2024 at 09:17, 2 years 2 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Cancer Treatment Conférences Heidelberg Pharma HDP-101 ADCs
PRESS RELEASE published on 05/23/2024 at 09:12, 2 years 2 months ago Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024 Heidelberg Pharma AG to participate and present at leading scientific conferences in May and June 2024, showcasing innovative ADC technology platforms for cancer treatment Cancer Treatment ADC Technology Heidelberg Pharma AG Scientific Conferences Clinical Stage Biotech
BRIEF published on 04/25/2024 at 07:26, 2 years 3 months ago Heidelberg Pharma AG Reports on Q1 2024 Financials and Operational Progress Financial Performance CEO Appointment Heidelberg Pharma AG HDP-101 Clinical Trial ADC Pipeline Development
PRESS RELEASE published on 04/25/2024 at 07:21, 2 years 3 months ago Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024 Heidelberg Pharma AG reports on its interim management statement for the first three months of 2024, including first efficacy data from a clinical trial and successful financing activities Clinical Trial Heidelberg Pharma AG ADC Pipeline Interim Statement Financing Activities
Published on 07/30/2026 at 04:10, 6 hours 38 minutes ago Pathfinder Ventures Announces Appointment of Mark Roseborough as Chief Executive Officer
Published on 07/30/2026 at 01:50, 8 hours 58 minutes ago Further Assays Infill Tunkillia Pit Extension Targets
Published on 07/30/2026 at 00:50, 9 hours 58 minutes ago Aton Announces Strategic Cooperation Relationship and Board Nominee
Published on 07/30/2026 at 00:00, 10 hours 48 minutes ago American Hotel Income Properties REIT LP to Host Second Quarter 2026 Results Conference Call on August 6, 2026
Published on 07/29/2026 at 23:01, 11 hours 47 minutes ago Blueberries Medical Announces C$1.1 Million Non-Brokered Private Placement
Published on 07/30/2026 at 10:26, 22 minutes ago Turkiye Garanti Bankasi A.S.: BRSA Consolidated Earnings Presentation dated 30 July 2026
Published on 07/30/2026 at 10:05, 43 minutes ago Elsa Hosk Becomes the Face of Popular Haircare Brand Lunesi
Published on 07/30/2026 at 10:00, 48 minutes ago CEOTRONICS AG receives three orders worth approximately €1.9 Million in total
Published on 07/30/2026 at 09:30, 1 hour 18 minutes ago TCMA and GIZ push low-carbon technologies to drive cement sector toward Net Zero 2050
Published on 07/30/2026 at 09:05, 1 hour 43 minutes ago in-lite introduces in-lite Smart AI: the next step in smart outdoor lighting
Published on 07/30/2026 at 09:07, 1 hour 41 minutes ago CNP Assicura, a subsidiary of CNP Assurances in Italy, announces an exclusive partnership with Fineco bank in the life insurance segment
Published on 07/30/2026 at 07:30, 3 hours 18 minutes ago Availability of the 2026 Interim Financial Report
Published on 07/30/2026 at 07:30, 3 hours 18 minutes ago Half-year 2026: Accor shows its agility in a challenging global environment
Published on 07/30/2026 at 07:00, 3 hours 48 minutes ago Mersen 2026 guidance raised after strong momentum in the first half
